PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,189 | -22.3% | 152,311 | -20.8% | 0.00% | – |
| Q2 2023 | $1,204,324 | +286643.8% | 192,384 | +118.4% | 0.00% | – |
| Q1 2023 | $420 | -51.1% | 88,097 | -10.7% | 0.00% | – |
| Q4 2022 | $859 | -99.9% | 98,697 | -15.2% | 0.00% | -100.0% |
| Q3 2022 | $1,385,000 | -17.0% | 116,411 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $1,668,000 | +9.7% | 116,999 | +38.5% | 0.00% | – |
| Q1 2022 | $1,521,000 | -35.4% | 84,484 | -17.1% | 0.00% | -100.0% |
| Q4 2021 | $2,355,000 | -26.3% | 101,972 | -4.9% | 0.00% | 0.0% |
| Q3 2021 | $3,197,000 | -7.7% | 107,265 | +5.8% | 0.00% | 0.0% |
| Q2 2021 | $3,464,000 | +70.3% | 101,400 | +63.9% | 0.00% | 0.0% |
| Q1 2021 | $2,034,000 | -33.9% | 61,858 | +23.7% | 0.00% | 0.0% |
| Q4 2020 | $3,077,000 | – | 50,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |